Category: Research News

This article is a correction from the original that inadvertently stated that defactinib was approved by the U.S. FDA. It should have said paclitaxel was approved by the FDA. In November, MesotheliomaHelp announced the start of the global clinical trial named COMMAND (Control Of Mesothelioma with MAiNtenance Defactinib), to assess the overall survival and progression …

An ingenious technique that has vanquished leukemia in a handful of patients is also being applied to mesothelioma. The strategy combines parts of the immune system in a way that targets cancer cells. The New York Times reported two of the leukemia cases. “An Immune System Trained to Kill Cancer” tells the story of the …

Researchers at McGill University and the University of Montreal conducting a follow-up study to the previous findings that the diabetic medication metformin can slow the growth of lung cancer cells, and potentially suppress mesothelioma growth, not only confirmed the results, but they also have a better understanding of how the drug works to fight cancer.   …